Cryopreserving Cells: Principles, Protocols, and Pitfalls

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Cell Cryopreservation

Cryopreservation is the process of preserving living cells, tissues, or other biological materials by cooling them to sub-zero temperatures, typically −80°C or −196°C (liquid nitrogen), where metabolic activity effectively ceases. At these temperatures, the biochemical reactions that drive cell metabolism—enzymatic catalysis, ATP production, membrane transport—are halted because water, the solvent in which these reactions occur, is frozen. The practical outcome is that cells can be stored for years or decades and, when properly thawed, resume normal function with high viability.

In research and biotechnology, cryopreservation is indispensable. Cell lines used for experiments, such as HEK293 or HeLa cells, must be maintained in culture, but continuous passage leads to genetic drift, phenotypic changes, and contamination risk. Cryopreservation creates a "cell bank" at an early passage number, allowing researchers to return to a defined, characterized stock rather than relying on cells that have undergone hundreds of population doublings. In medicine, cryopreservation underpins stem cell transplantation, assisted reproduction, and the storage of patient-derived cells for future therapeutic use. The same principles apply whether you are freezing a clonal population of Stellar Competent Cells or a primary human cell line.

Why Cryopreserve Cells?

The primary reasons to cryopreserve cells are:

1. Genetic stability: Cells in continuous culture accumulate mutations. Freezing at a low passage number preserves the original genotype.
2. Contamination control: Long-term culture increases the risk of mycoplasma, bacterial, or cross-cell-line contamination. Frozen stocks provide a clean backup.
3. Resource management: Maintaining multiple cell lines simultaneously is labor-intensive and expensive. Cryopreservation allows you to store lines and expand them only when needed.
4. Experimental reproducibility: Using cells from a defined frozen stock ensures that experiments are performed with cells of known provenance and passage history.
5. Clinical application: For cell-based therapies, cryopreservation enables quality control, transport, and timed administration of cells.

The Challenge of Ice Formation

The central problem in cryopreservation is that water, which constitutes 70–85% of a cell's mass, forms ice when cooled below its freezing point. Ice crystal formation is lethal to cells through several mechanisms. Extracellular ice can physically crush cells as it expands. Intracellular ice, which forms when water freezes inside the cytoplasm, is almost invariably fatal because ice crystals disrupt organelles, puncture membranes, and denature proteins. Additionally, as water leaves the cell to form extracellular ice, the remaining intracellular solutes become concentrated, creating osmotic stress that can shrink the cell beyond its capacity to recover.

The goal of cryopreservation is therefore not to prevent freezing entirely—that would require impractical pressures or massive concentrations of solutes—but to control the freezing process so that ice forms only extracellularly, while the cell interior remains in a vitrified (glass-like) state or is dehydrated to the point where intracellular ice cannot form. This is achieved through a combination of cryoprotective agents (CPAs) and carefully controlled cooling rates.

Principles of Cryobiology

Understanding cryopreservation requires grasping the physical chemistry of water at low temperatures and how cells respond to the stresses of freezing and thawing.

Ice Crystal Formation and Cell Damage

When a cell suspension is cooled below 0°C, ice nucleation typically begins in the extracellular medium rather than inside the cell. This is because the extracellular solution contains particulate matter and solutes that serve as nucleation sites, and the cell membrane acts as a barrier to ice propagation. As extracellular ice forms, pure water is sequestered into ice crystals, leaving the remaining extracellular fluid increasingly concentrated with salts and other solutes. This creates an osmotic gradient: the extracellular osmolality rises, and water is drawn out of the cell to equilibrate. The cell shrinks.

If cooling is very rapid, water does not have time to leave the cell before the intracellular temperature drops below the point where ice can form. The result is intracellular ice—small, numerous crystals that form throughout the cytoplasm. These crystals mechanically disrupt the plasma membrane and intracellular structures, and upon thawing, the cell is irreversibly damaged.

If cooling is very slow, cells dehydrate extensively. While this avoids intracellular ice, prolonged exposure to hypertonic conditions damages cells through a phenomenon known as "solution effects"—the concentrated intracellular solutes can denature proteins, destabilize membranes, and cause excessive shrinkage. There is a middle ground, described by the two-factor hypothesis.

Cooling Rate and Cell Survival

The two-factor hypothesis, first articulated by Peter Mazur in the 1960s, states that cell survival after freezing and thawing depends on the cooling rate, and that there is an optimal rate that balances two competing forms of damage:

• Too slow: Cells are exposed to concentrated solutes for too long, causing solution effects damage.
• Too fast: Water cannot exit the cell quickly enough, leading to intracellular ice formation.

The optimal cooling rate depends on the cell's water permeability and surface-area-to-volume ratio. For most mammalian cells, the optimal rate is between 1°C and 3°C per minute. Red blood cells, which are small and have high water permeability, tolerate faster cooling (around 100°C/min), while larger cells like oocytes or embryos require slower cooling (0.3–0.5°C/min). The relationship is typically plotted as an inverted U-shaped curve, with survival on the y-axis and cooling rate on the x-axis.

During thawing, the reverse process occurs. If thawing is slow, small ice crystals can recrystallize—grow larger by fusing with neighboring crystals—which is mechanically destructive. Rapid thawing minimizes recrystallization by passing quickly through the temperature range where ice crystals grow most rapidly (approximately −50°C to 0°C). This is why the standard protocol calls for thawing cells quickly in a 37°C water bath.

Cryoprotective Agents (CPAs)

Cryoprotective agents are compounds added to the freezing medium to protect cells from ice-related damage. They fall into two broad categories: permeating agents, which enter the cell, and non-permeating agents, which remain extracellular.

Permeating Agents: DMSO and Glycerol

Permeating CPAs are small, water-soluble molecules that cross the plasma membrane and accumulate inside the cell. Their primary mechanism of action is colligative: they increase the total solute concentration inside the cell, reducing the amount of water available to form ice and lowering the temperature at which ice forms. They also bind water molecules, reducing ice crystal growth, and stabilize proteins and membranes through direct interactions.

Dimethyl sulfoxide (DMSO) is the most widely used permeating CPA for mammalian cells. It is typically used at a final concentration of 5–10% (v/v). DMSO penetrates cells rapidly, within minutes at room temperature, and is effective across a wide range of cell types. Its drawbacks include cytotoxicity at higher concentrations or prolonged exposure, and the fact that it can induce differentiation in some stem cell lines. DMSO also lowers the freezing point of the medium, which means the sample may not be completely frozen until well below −20°C.

Glycerol is another permeating CPA, commonly used for red blood cells, sperm, and some bacterial strains. It is less toxic than DMSO but penetrates more slowly, requiring longer equilibration times. Glycerol is often used at concentrations of 10–20% (v/v).

Both agents work by the same fundamental principle: they reduce the fraction of water that freezes at any given temperature, thereby reducing the osmotic stress on the cell and preventing intracellular ice formation.

Non-Permeating Agents: Sugars and Polymers

Non-permeating CPAs remain in the extracellular space. They protect cells through two mechanisms: they draw water out of the cell (creating a mild dehydration that reduces intracellular ice) and they stabilize the cell membrane through direct interaction with the lipid bilayer.

Sucrose and trehalose are common non-permeating sugars. Trehalose is particularly effective because it interacts with phospholipid head groups, stabilizing membranes during dehydration. These sugars are often added to freezing media at concentrations of 0.1–0.5 M.

Polymers such as polyvinylpyrrolidone (PVP), hydroxyethyl starch (HES), and polyethylene glycol (PEG) are also used. These large molecules cannot enter the cell; they protect by forming a viscous extracellular matrix that slows ice crystal growth and by promoting a glassy state (vitrification) at low temperatures. Fetal bovine serum (FBS), typically used at 10–20% in freezing media, also provides some cryoprotection through its protein content, which stabilizes membranes and buffers against pH changes.

In practice, most freezing media combine a permeating CPA (usually DMSO) with a non-permeating agent (serum or a sugar) to achieve synergistic protection.

Standard Cryopreservation Protocol

The following protocol is a general method for cryopreserving adherent or suspension mammalian cells. Specific cell types may require modifications, but the principles are universal.

Preparing Cells for Freezing

Cells should be in logarithmic growth phase—actively dividing and at 70–80% confluency for adherent cells—at the time of freezing. Cells that are overconfluent, starved, or stressed will survive freezing poorly. The day before freezing, it is often advisable to feed the cells with fresh medium.

For adherent cells:

1. Remove the culture medium and wash the monolayer with phosphate-buffered saline (PBS) without calcium and magnesium to remove residual serum.
2. Add trypsin-EDTA (0.05% trypsin, 0.02% EDTA) sufficient to cover the monolayer. Incubate at 37°C for 2–5 minutes until cells detach.
3. Neutralize the trypsin by adding complete medium containing serum (serum contains trypsin inhibitors).
4. Transfer the cell suspension to a centrifuge tube.

For suspension cells, skip the trypsinization step and proceed directly to centrifugation.

1. Count the cells using a hemocytometer or automated counter.
2. Centrifuge at 200–300 × g for 5–10 minutes at room temperature.
3. Remove the supernatant completely. Residual trypsin or medium will dilute the freezing medium and reduce its effectiveness.

Freezing Medium and Cell Density

The standard freezing medium for most mammalian cells is:

• 70% complete growth medium
• 20% fetal bovine serum (FBS)
• 10% DMSO

Some protocols use 90% FBS + 10% DMSO, which provides maximal protein protection but is more expensive. For serum-free or defined media, commercial freezing solutions such as CryoStor or Recovery Cell Culture Freezing Medium are available; these contain proprietary combinations of CPAs and are formulated for specific cell types.

The cell density for freezing should be between 1 × 10⁶ and 1 × 10⁷ viable cells per milliliter. Higher densities can lead to clumping and reduced viability; lower densities may result in poor recovery because cell–cell contact provides some protection during freezing.

Resuspend the cell pellet gently in ice-cold freezing medium. Do not vortex. Work quickly, as DMSO is toxic to cells at room temperature over extended periods. The entire process from resuspension to placement in the freezing container should take no more than 10–15 minutes.

Controlled-Rate vs. −80°C Freezing

The optimal cooling rate for most mammalian cells is approximately −1°C per minute. There are two ways to achieve this:

Controlled-rate freezers are programmable devices that cool samples at a precisely defined rate by injecting liquid nitrogen into a chamber. These are used for sensitive cells—embryos, stem cells, primary cells—where even small deviations from the optimal rate reduce viability. They are expensive and primarily found in core facilities and clinical laboratories.

Isopropanol freezing containers (e.g., Mr. Frosty) are the standard laboratory alternative. These are sealed containers that hold cryovials and contain 250 mL of isopropanol. When placed in a −80°C freezer, the isopropanol cools at approximately −1°C per minute because its thermal mass buffers the cooling rate. The container must be used with fresh isopropanol and pre-chilled to 4°C before use. This method is adequate for most established cell lines.

For cells that are particularly sensitive, an alternative is to place the cryovials in a foam box or insulated container in the −80°C freezer, which slows cooling. However, this is less reproducible than using a commercial freezing container.

After 24 hours at −80°C, the cells are frozen and can be transferred to liquid nitrogen for long-term storage. If cells are kept at −80°C for more than a few weeks, viability declines because ice crystals slowly recrystallize at this temperature.

Thawing and Recovery of Cryopreserved Cells

Proper thawing is as important as proper freezing. The goal is to pass through the dangerous temperature zone (−50°C to 0°C) as quickly as possible to prevent ice recrystallization.

Rapid Thawing Technique

1. Remove the cryovial from liquid nitrogen or −80°C storage. Do not loosen the cap until the vial is thawed—liquid nitrogen that has seeped into the threads can cause the vial to explode when the cap is loosened.
2. Place the vial in a 37°C water bath, with the O-ring and cap above the water line to prevent contamination.
3. Agitate gently until only a small ice crystal remains, typically 1–2 minutes. Do not leave the vial in the water bath longer than necessary, as warming above 37°C damages cells.
4. Wipe the vial with 70% ethanol and transfer to a biosafety cabinet.

Removing Cryoprotectant

DMSO is toxic to cells at 37°C, so it must be removed promptly after thawing. The standard procedure is:

1. Transfer the thawed cell suspension to a centrifuge tube containing 10 mL of pre-warmed complete medium. The dilution reduces the DMSO concentration to approximately 1%, which is below the toxic threshold.
2. Centrifuge at 200–300 × g for 5 minutes.
3. Remove the supernatant and resuspend the cell pellet in fresh complete medium.
4. Plate the cells in a culture vessel at an appropriate density.

Some protocols recommend adding the thawed cells dropwise to the medium rather than in one bolus, to reduce osmotic shock. For particularly sensitive cells, a stepwise dilution—adding 1 mL of medium, waiting 1 minute, then adding the rest—can improve viability.

Assessing Viability and Function

Post-thaw viability should be assessed within a few hours of plating. The most common method is the trypan blue exclusion assay: trypan blue is a dye that enters cells with compromised membranes, so viable cells exclude it. Mix equal volumes of cell suspension and 0.4% trypan blue, load onto a hemocytometer, and count the percentage of unstained cells. Viability above 70% is generally acceptable for established cell lines; primary cells and stem cells may show lower recovery.

Functional assessment—confirming that cells proliferate, express appropriate markers, or respond to stimuli—is more meaningful than viability alone. For example, after thawing CRISPR in T Cells experiments, you would verify that the T cells still proliferate in response to anti-CD3/CD28 stimulation. For adherent cells, confirm that they attach and spread within 24 hours. For cells used in downstream applications such as transformation, you would verify that the cells retain the expected efficiency—this is particularly relevant when working with Chemically Competent Cells, where post-thaw transformation efficiency is the true measure of success.

Factors Affecting Cryopreservation Success

Not all cells cryopreserve equally well. Several variables determine the outcome, and understanding them allows you to troubleshoot failures.

Cell Type and Source

Different cell types have different optimal cooling rates and CPA requirements. Immortalized cell lines (HeLa, HEK293, CHO) are generally robust and survive standard protocols well. Primary cells, which are freshly isolated from tissue, are more sensitive and often require modified protocols. Stem cells, particularly induced pluripotent stem cells (iPSCs), are notoriously difficult to cryopreserve; they often require slow cooling, higher CPA concentrations, and the addition of ROCK inhibitor (Y-27632) to prevent apoptosis after thawing.

Bacteria and yeast have cell walls that make them more resistant to osmotic stress, but they still require CPAs. For bacteria, glycerol at 15–25% (v/v) is standard. The protocol for Making Competent Cells typically includes a glycerol-containing storage buffer because competent cells are routinely frozen for later use. Similarly, Top10 Competent Cells are stored at −80°C in a glycerol-based buffer.

Cell Health and Culture Conditions

Cells that are stressed, senescent, or in poor condition before freezing will not survive well. Key factors include:

• Passage number: Cells at high passage may have accumulated genetic and epigenetic changes that reduce their resilience. Freeze cells at the lowest practical passage number.
• Confluency: Freeze cells at 70–80% confluency. Overconfluent cells are contact-inhibited and may be in a different metabolic state.
• Nutrient status: Cells should be fed with fresh medium 24 hours before freezing. Starved cells are more vulnerable to cryoinjury.
• Mycoplasma contamination: Mycoplasma-infected cells show reduced viability after thawing. Regular mycoplasma testing is essential.

Quality of DMSO and Serum

DMSO is hygroscopic and can absorb water over time, which reduces its effectiveness and introduces impurities. Use fresh, high-quality DMSO (cell culture grade, ≥99.7% purity) and store it in small aliquots under nitrogen or desiccant. DMSO that has been opened repeatedly or stored for months should be discarded.

Serum quality also matters. FBS varies between lots in its protein composition and cryoprotective capacity. For critical applications, test multiple lots and reserve a consistent supply. Heat-inactivated serum (56°C for 30 minutes) is sometimes used to inactivate complement, but this also reduces some protective proteins; for cryopreservation, non-heat-inactivated serum is generally preferred.

Long-Term Storage and Inventory Management

Proper storage conditions and record-keeping are essential for maintaining a viable cell bank over years.

Storage Temperatures and Stability

There are two common storage temperatures:

• −80°C (mechanical freezer): Suitable for short-term storage (weeks to a few months). At this temperature, ice crystals slowly recrystallize, and enzymatic activity, while greatly reduced, is not entirely absent. Viability declines progressively.
• −196°C (liquid nitrogen, vapor phase): Suitable for long-term storage (years to decades). At this temperature, all metabolic activity ceases, and ice crystal growth is negligible. Storage in the vapor phase above liquid nitrogen (approximately −150°C to −190°C) is preferred over immersion in the liquid phase because it eliminates the risk of vials exploding due to liquid nitrogen entering and then expanding during thawing, and it reduces the risk of cross-contamination between samples.

For critical cell lines, the gold standard is to store cells in both locations: a working bank at −80°C for routine use and a master bank in liquid nitrogen that is only accessed when the working bank is depleted.

Labeling and Database Management

A cryopreserved cell line is worthless if you cannot identify it. Every vial must be labeled with:

• Cell line name and passage number
• Date of freezing
• Freezing medium composition
• Initials of the person who prepared the vials
• A unique identifier (e.g., barcode or number) that links to a database

The database should record the full history: source of the cells, culture conditions, mycoplasma test results, and any genetic modifications. For genetically modified cells, this includes the specific construct and selection markers. This is particularly important when working with engineered lines, such as those used in CRISPR Delivered to Cells experiments, where the exact clone and modification must be traceable.

Common Pitfalls and Troubleshooting

Even with careful technique, cryopreservation can fail. The following are the most common problems and their solutions.

Low Viability After Thaw

Symptoms: Viability below 50% immediately after thaw, or cells that fail to attach and proliferate within 48 hours.

Possible causes and solutions:

Cell Clumping or Debris

Symptoms: Large aggregates of dead cells and debris after thawing, poor attachment.

Possible causes and solutions:

• Overdigestion with trypsin: Reduce trypsin exposure time; neutralize promptly with serum-containing medium.
• DNA release from dead cells: Add DNase I (10 µg/mL) to the thawing medium to digest DNA released from lysed cells.
• Centrifugation too harsh: Reduce centrifugation speed to 200 × g and time to 5 minutes.
• Pipetting too vigorously: Use a serological pipette and gentle trituration to break up clumps.

Contamination Risks

Symptoms: Cloudy medium, pH change, or visible microbial growth within days of thawing.

Possible causes and solutions:

• Water bath contamination: Ensure the water bath is clean and contains a bacteriostatic agent; wipe vials with 70% ethanol before opening.
• Liquid nitrogen cross-contamination: Store vials in the vapor phase, not immersed in liquid; use sealed cryovials or straws.
• Antibiotic-free medium: Some labs freeze cells without antibiotics to avoid masking contamination. If you use antibiotics in culture, include them in the freezing medium.
• Mycoplasma: Test cells regularly; mycoplasma is not visible by eye and requires PCR or Hoechst staining to detect.

Summary and Best Practices

Successful cryopreservation depends on controlling three variables: the composition of the freezing medium, the cooling rate, and the thawing rate. The principles are universal, but each cell type requires optimization.

Quick Reference Checklist

Before freezing:

• [ ] Cells are at 70–80% confluency, low passage, mycoplasma-free
• [ ] Cells fed with fresh medium 24 hours prior
• [ ] Freezing medium prepared fresh: 70% growth medium, 20% FBS, 10% DMSO
• [ ] DMSO is fresh, high quality, and stored properly
• [ ] Isopropanol freezing container pre-chilled to 4°C

During freezing:

• [ ] Cells counted and adjusted to 1–5 × 10⁶ cells/mL
• [ ] Cells resuspended gently in ice-cold freezing medium
• [ ] Aliquoted into labeled cryovials (1 mL per vial)
• [ ] Placed in freezing container within 10 minutes of adding DMSO
• [ ] Transferred to −80°C freezer immediately

After 24 hours:

• [ ] Vials transferred to liquid nitrogen vapor phase for long-term storage
• [ ] Inventory database updated with vial location and details

During thawing:

• [ ] Vial thawed in 37°C water bath with gentle agitation (1–2 minutes)
• [ ] Cells diluted immediately in 10 mL pre-warmed medium
• [ ] Centrifuged at 200 × g for 5 minutes
• [ ] Supernatant removed; cells resuspended in fresh medium
• [ ] Viability assessed by trypan blue exclusion
• [ ] Cells monitored for attachment and proliferation over 48 hours

Frequently Asked Questions

How do you cryopreserve cells?

Cells are harvested in logarithmic growth phase, resuspended in freezing medium (typically 70% growth medium, 20% FBS, 10% DMSO) at a density of 1–5 × 10⁶ cells/mL, and cooled at approximately −1°C per minute to −80°C. After 24 hours, they are transferred to liquid nitrogen (−196°C) for long-term storage. Thawing is performed rapidly in a 37°C water bath, and the DMSO is removed by centrifugation and resuspension in fresh medium.

Why is DMSO used in cell cryopreservation?

DMSO is a permeating cryoprotective agent. It crosses the cell membrane and accumulates intracellularly, where it binds water and reduces ice crystal formation. It also lowers the freezing point of the medium and stabilizes proteins and membranes. DMSO is used at 5–10% (v/v) because it is effective at these concentrations and relatively less toxic than alternatives, though it must be removed promptly after thawing.

What is the optimal cooling rate for freezing cells?

For most mammalian cells, the optimal cooling rate is approximately −1°C per minute. This rate balances two forms of damage: too slow causes damage from concentrated solutes (solution effects), and too fast causes intracellular ice formation. The optimal rate varies by cell type—small, highly permeable cells tolerate faster cooling, while large cells like oocytes require slower cooling.

Can you freeze cells at −80°C?

Yes, cells can be frozen at −80°C, and this is acceptable for short-term storage (weeks to a few months). However, at −80°C, ice crystals slowly recrystallize and metabolic activity is reduced but not entirely halted, so viability declines over time. For long-term storage (years), cells must be transferred to liquid nitrogen at −196°C.

How long can cells be stored in liquid nitrogen?

At −196°C, all metabolic activity ceases and ice crystal growth is negligible. Cells stored properly in liquid nitrogen can remain viable for decades. The practical limit is usually determined by the quality of the initial freezing and the stability of the storage conditions, not by the passage of time itself.

What happens if you thaw cells too slowly?

Slow thawing allows ice crystals to recrystallize—small crystals fuse into larger ones—which mechanically damages cell membranes and organelles. It also prolongs exposure to high concentrations of DMSO and solutes at temperatures where they are toxic. The result is significantly reduced viability. Thawing should be rapid (1–2 minutes in a 37°C water bath) to pass quickly through the dangerous temperature range of −50°C to 0°C.

Why do my cells die after thawing?

Cell death after thawing can result from several factors: freezing cells at too high a density, DMSO toxicity due to prolonged exposure at room temperature, incorrect cooling rate (either too fast or too slow), thawing too slowly, inadequate CPA concentration, or freezing cells that were unhealthy (overconfluent, high passage, or contaminated). Systematic troubleshooting—checking each step of the protocol—is the most effective way to identify the cause.

Key Takeaways

• Cryopreservation preserves cells by halting metabolic activity at ultra-low temperatures, but ice formation is the primary cause of cell damage and must be controlled.
• The two-factor hypothesis explains that there is an optimal cooling rate (approximately −1°C/min for most mammalian cells) that balances solution effects damage (too slow) against intracellular ice formation (too fast).
• Cryoprotective agents fall into two classes: permeating agents like DMSO and glycerol, which enter cells and reduce ice formation, and non-permeating agents like sucrose, trehalose, and serum proteins, which act extracellularly.
• The standard freezing medium is 70% growth medium, 20% FBS, and 10% DMSO, with cells frozen at 1–5 × 10⁶ cells/mL.
• Rapid thawing in a 37°C water bath is critical to prevent ice recrystallization, and DMSO must be removed promptly after thawing because it is cytotoxic at physiological temperatures.
• Long-term storage requires liquid nitrogen (−196°C); −80°C storage is only suitable for short-term use.
• Cell health before freezing, quality of reagents, and meticulous record-keeping are as important as the freezing protocol itself for successful cryopreservation.

Further Reading

• Ciftci YO , Kaya E . Transcriptomics of cryopreserved cells. Cryo letters. 2024. PubMed 40089818
• Modaresi S et al. Engineering a Microfluidic Platform to Cryopreserve Stem Cells: A DMSO-Free Sustainable Approach. Advanced healthcare materials. 2024. PubMed 39152923
• Gilfanova R et al. Reduced dimethyl sulfoxide concentrations successfully cryopreserve human hematopoietic stem cells with multi-lineage long-term engraftment ability in mice. Cytotherapy. 2021. PubMed 34454842

Related Clinical & Scientific Guides

• MAPK Pathway: Mechanism, Function, and Clinical Relevance
• Mammalian Cell Culture Bioreactors: A Practical Guide
• Nucleotide Formation: Biosynthesis and Assembly of DNA/RNA Building Blocks